Early Detection Research Network


This biomarker is also known as:
  • Cardiac lineage protein 1,
  • cardiac lineage protein 1,
  • hexamethylene bis-acetamide inducible 1,
  • hexamethylene-bis-acetamide-inducible transcript 1,
  • HIS1,
  • Estrogen down-regulated gene 1 protein,
  • HMBA-inducible,
  • Hexamethylene bis-acetamide-inducible protein 1,
  • menage a quatre protein 1,
  • MAQ1,
  • protein HEXIM1,
  • CLP-1,
  • hexamethylene bisacetamide-inducible protein,
  • menage a quatre 1,
  • HEXIM1,
  • Menage a quatre protein 1,
  • hexamethylene bis-acetamide-inducible protein 1,
  • estrogen down-regulated gene 1 protein,
  • hexamthylene bis-acetamide inducible 1,
  • EDG1,
  • CLP1,


HEXIM1 is an intronless transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor. HEXIM1 expression is induced by hexamethylene-bis-acetamide in vascular smooth muscle cells.


There are no datasets associated with this biomarker.

QA State: Curated
Type: Protein

The following organs have data associated with this biomarker…


Phase: Two
QA State: Under Review


No additional breast data available.

Performance Comment

HEXIM1 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.